Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2000-08-23 · United States International Trade Commission · Proposed Rules

Proposed Rules. Extension of dates for delivery of the initial report and for written submissions by interested parties for Inv

551 words·~3 min read·/register/2000/08/23/00-21501

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 7020-02-U INTERNATIONAL TRADE COMMISSION [Investigation 332-419] Pricing of Prescription Drugs AGENCY: United States International Trade Commission ACTION: Extension of dates for delivery of the initial report and for written submissions by interested parties for Inv. No. 332-419, Pricing of Prescription Drugs. EFFECTIVE DATE: August 17, 2000. SUMMARY: In response to a request on August 9, 2000, from the Committee on Ways and Means (the Committee) of the United States House of Representatives, the Commission has extended the date for reporting the initial results of its investigation No. 332-419, Pricing of Prescription Drugs, until December 1, 2000.
The deadline for written submissions by interested parties has been extended to September 8, 2000. FOR FURTHER INFORMATION CONTACT: Elizabeth R. Nesbitt, Project Leader (202-205-3355) or Raymond L. Cantrell, Deputy Project Leader (202-205-3362), Office of Industries, or Michael Barry, Deputy Project Leader (202-205-3246), Office of Economics, U.S. International Trade Commission, Washington, DC, 20436. For information on the legal aspects of this investigation, contact William Gearhart of the Office of the General Counsel (202-205-3091).
Hearing impaired individuals are advised that information on this matter can be obtained by contacting the TDD terminal on
(202)205-1810. WRITTEN SUBMISSIONS: The deadline for written submissions has been extended until September 8, 2000. Interested parties are invited to submit written statements (original and 14 copies) concerning the matters to be addressed by the Commission in its report on this investigation. In addition to general information regarding prices and pricing practices prevalent in each of the countries under consideration, the Commission is particularly interested in comments regarding the question raised by the Committee in their request regarding the extent to which price control systems utilized by the countries under consideration impact pricing for comparable drugs in the United States. Commercial or financial information that a person desires the Commission to treat as confidential must be submitted on separate sheets of paper, each clearly marked “Confidential Business Information” at the top. All submissions requesting confidential treatment must conform with the requirements of § 201.6 of the Commission's Rules of Practice and Procedure (19 CFR 201.6). All written submissions must conform with the provisions of section 201.8 of the Commission's Rules. All written submissions, except for confidential business information, will be made available in the Office of the Secretary of the Commission for inspection by interested parties. To be assured of consideration by the Commission, written statements relating to the Commission's report should be submitted to the Commission at the earliest practical date and should be received no later than the close of business on September 8, 2000. All submissions should be addressed to the Secretary, United States International Trade Commission, 500 E Street SW., Washington, DC 20436. The Commission's rules do not authorize filing submissions with the Secretary by facsimile or electronic means. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202-205-2000. General information concerning the Commission may also be obtained by accessing its Internet server (http://www.usitc.gov). Notice of institution of the investigation was published in the **Federal Register** of July 26, 2000 (65 FR 45998). List of Subjects Prescription drugs, Price controls, Compulsory licensing. By order of the Commission. Issued: August 17, 2000. Donna R. Koehnke, Secretary. [FR Doc. 00-21501 Filed 8-22-00; 8:45 am]
Connectionstraces to 1
Citation graph
cites case law
Proposed Rules
Extension of dates for delivery of the initial report and for written submissions by interested parties for Inv
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.